Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers

Healthy, Male Clinical Trial

Official title: A Dose-block Randomized, Active-controlled, Open-label Clinical Study to Compare Pharmacokinetic Property of SYO-1644 Tab and Nexavar Tab in Healthy Male Volunteers

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the pharmacokinetics characteristics ,tolerability, and safety after orally administrating SYO-1644 to healthy male volunteers in randomized, active-controlled, open-label clinical study.

Clinical Trial Description

After orally administrating SYO-1644 and Nexavar 200 mg to healthy male participants , the safety, tolerability, and pharmacokinetic characteristics are to be compared while testing pharmacokinetic characteristics based on the dosage. ;

Related Conditions & MeSH terms

• Healthy, Male

• NCT number: NCT03674060
• Study type: Interventional
• Source: Samyang Biopharmaceuticals Corporation
• Status: Completed
• Phase: Phase 1
• Start date: October 28, 2018
• Completion date: July 23, 2019